• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session

    9/20/22 12:41:48 PM ET
    $ADXN
    $AKA
    $ARAV
    $BCAN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $ADXN alert in real time by email

    Gainers

    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) gained 47.7% to $3.6493 after the company announced the distribution of a Monkeypox Virus Antigen Rapid Test Kits which has been launched in markets accepting the CE mark, such as the European Union.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares gained 25.8% to $6.92. BYND Cannasoft shares jumped over 32% on Monday after the company announced it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments for $28 million in stock.
    • TRxADE HEALTH, Inc. (NASDAQ:MEDS) jumped 24.7% to $1.3299 after the company announced Bonum Health, a subsidiary, signed a Telemedicine Services Distribution Deal with Wakefern Food, to deploy telemedicine services throughout ShopRite pharmacy-led locations in New Jersey, New York, Pennsylvania, Connecticut and Maryland.
    • GigaCloud Technology Inc. (NASDAQ:GCT) gained 19.8% to $15.90.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares gained 19.4% to $2.89 after gaining over 4% on Monday.
    • a.k.a. Brands Holding Corp. (NYSE:AKA) jumped 18.8% to $1.7112.
    • SeqLL Inc. (NASDAQ:SQL) gained 16.1% to $0.9333.
    • Renovacor, Inc. (NYSE:RCOR) jumped 14.7% to $2.1794. Rocket Pharmaceuticals agreed to acquire Renovacor in an all-stock transaction for an implied value of approximately $2.60 per share.
    • Amprius Technologies, Inc. (NYSE:AMPX) rose 13.5% to $6.70.
    • Studio City International Holdings Limited (NYSE:MSC) gained 13.5% to $2.3150.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) rose 13% to $1.90 after gaining 5% on Monday.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) rose 12.2% to $0.96 after declining around 9% on Monday.
    • O2Micro International Limited (NASDAQ:OIIM) rose 10.2% to $3.25 after the company announced receipt of a revised preliminary non-binding proposal to acquire the company.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) gained 10% to $2.7301.
    • Melco Resorts & Entertainment Limited (NASDAQ:MLCO) rose 9.7% to $6.39.
    • AEA-Bridges Impact Corp. (NYSE:IMPX) gained 9.3% to $10.80.
    • Innoviz Technologies Ltd. (NASDAQ:INVZ) gained 8.9% to $6.03 after JP Morgan initiated coverage on the stock with an Overweight rating and announced a $22 price target.
    • Cognex Corporation (NASDAQ:CGNX) rose 8.3% to $45.17 as the company boosted its guidance for the third quarter.
    • bluebird bio, Inc. (NASDAQ:BLUE) jumped 8% to $6.41. Raymond James maintained bluebird bio with an Outperform and raised the price target from $8 to $10.
    • RLX Technology Inc. (NYSE:RLX) gained 6.8% to $1.25.
    • Oxford Industries, Inc. (NYSE:OXM) climbed 6.8% to $96.11. Oxford Industries completed the acquisition of Johnny Was, a California-based affordable luxury apparel brand, for $270 million. Piper Sandler maintained Oxford Industries with an Overweight and raised the price target from $130 to $135.
    • Change Healthcare Inc. (NASDAQ:CHNG) rose 6.7% to $27.18 after a U.S. judge denied the Justice Department's request to stop UnitedHealth's $13 billion buyout deal for Change Healthcare.
    • Lyft, Inc. (NASDAQ:LYFT) gained 5.6% to $17.16.


    Losers

    • Virios Therapeutics, Inc. (NASDAQ:VIRI) fell 74.5% to $0.5079 after the company priced a 10 million share public offering at $0.50 per share. Also, HC Wainwright & Co downgraded the stock from Buy to Neutral.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) shares tumbled 58.9% to $2.87 after dropping 11% on Monday.
    • Cosmos Holdings Inc. (NASDAQ:COSM) dropped 38.6% to $0.2271.
    • Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) dipped 24.6% to $0.7982 as the U.S. FDA staff raised concerns over the safety of the company’s experimental cancer drug and questioned the benefits it provided over existing therapies.
    • Tellurian Inc. (NYSE:TELL) fell 22.5% to $3.0231.
    • Winc, Inc. (NYSE:WBEV) fell 20.5% to $0.7154 after jumping around 27% on Monday.
    • FOXO Technologies Inc. (NYSE:FOXO) dropped 16.8% to $2.0799.
    • Ventoux CCM Acquisition Corp. (NASDAQ:VTAQ) fell 16.3% to $5.90 after climbing around 55% on Monday.
    • MicroCloud Hologram Inc (NASDAQ:HOLO) dropped 14.9% to $2.5101.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 14.7% to $0.1439. Esports Entertainment recently priced a 30 million share plus warrant public offering at $0.25 per share plus warrant.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) fell 14% to $0.1333.
    • Sotera Health Company (NASDAQ:SHC) fell 13.7% to $8.50
    • CF Acquisition Corp. VI (NASDAQ:RUM) dipped 12.8% to $14.63.
    • Dawson Geophysical Company (NASDAQ:DWSN) fell 12.3% to $1.91.
    • Rockley Photonics Holdings Limited (NYSE:RKLY) dropped 11.8% to $1.0050.
    • Vericity, Inc. (NASDAQ:VERY) fell 9.6% to $6.60.
    • Ford Motor Company (NYSE:F) fell 9.1% to $13.57 after the company previewed the effect of parts shortages on the company in the third-quarter and said inflation-related supplier costs during the third quarter will run about $1.0 billion higher than originally expected. The company also projects to have about 40,000 to 45,000 vehicles in inventory at end of third quarter lacking certain parts presently in short supply.
    • Vor Biopharma Inc. (NASDAQ:VOR) dropped 7.2% to $4.27.
    • Aravive, Inc. (NASDAQ:ARAV) fell 7.1% to $0.9473.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) fell 6.4% to $1.15. Clovis Oncology recently submitted applications for Rubraca label expansion in the US and European Union as first-line maintenance treatment in women with advanced ovarian cancer.
    Get the next $ADXN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADXN
    $AKA
    $ARAV
    $BCAN

    CompanyDatePrice TargetRatingAnalyst
    Oxford Industries Inc.
    $OXM
    4/22/2026$36.00 → $51.00Market Perform
    Telsey Advisory Group
    Innoviz Technologies Ltd.
    $INVZ
    4/14/2026$0.75Buy → Neutral
    Goldman
    Ford Motor Company
    $F
    4/14/2026$15.00Neutral → Buy
    UBS
    Vor Biopharma Inc.
    $VOR
    3/30/2026$50.00Buy
    Jefferies
    Oxford Industries Inc.
    $OXM
    3/27/2026$40.00 → $36.00Market Perform
    Telsey Advisory Group
    Vor Biopharma Inc.
    $VOR
    3/19/2026$30.00Overweight
    Wells Fargo
    Cognex Corporation
    $CGNX
    3/9/2026$55.00Underweight → Neutral
    Analyst
    Ford Motor Company
    $F
    3/4/2026$17.00Buy
    BofA Securities
    More analyst ratings

    $ADXN
    $AKA
    $ARAV
    $BCAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RLX Technology Files 2025 Annual Report on Form 20-F

    SHENZHEN, China, April 23, 2026 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on April 23, 2026. The annual report on Form 20-F can be accessed on the SEC's website at https://www.sec.gov and on the Company's investor relations website at https://ir.relxtech.com. The Company will provide a hard copy of its  audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request.About RLX Technology Inc.RLX Technolo

    4/23/26 9:00:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    Lyft Expands in London with Gett UK Acquisition

    Key takeaways: Lyft has agreed to acquire Gett's United Kingdom business with close expected in the coming weeks, subject to customary closing conditions. Gett is one of London's leading black cab apps with strong enterprise business-to-business (B2B) relationships, and brings together the majority of Greater London's registered black cab drivers and will nearly double the number of rides on the Lyft platform in London. With Gett, Lyft is expanding its coverage of London's full ground transport ecosystem. This advances Lyft's sustainable global growth strategy, while expanding "out" in more locations and "up" into more high-value segments. Lyft (NASDAQ:LYFT) has agreed to acq

    4/23/26 8:48:00 AM ET
    $LYFT
    Real Estate

    Innoviz Sets First Quarter 2026 Conference Call for Thursday, May 14 at 9:00 a.m. ET

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- Innoviz Technologies Ltd. (NASDAQ:INVZ), (the "Company" or "Innoviz"), a leading supplier of high performance, automotive-grade LiDAR sensor platforms, today announced that it will release its earnings results for the first quarter ended March 31, 2026 on Thursday, May 14, 2026 before the market opens. Innoviz will host a conference call and webinar on the same day at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time) to discuss its operational and financial results followed by a question-and-answer session for the investment community. Operational and financial results will be issued in a press release prior to the call.Investors are invited to

    4/23/26 8:00:00 AM ET
    $INVZ
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ADXN
    $AKA
    $ARAV
    $BCAN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADXN
    $AKA
    $ARAV
    $BCAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chair and Chair Ford William Clay Jr received a gift of 2,750 units of Class B Stock, bought $1,934,450 worth of Class B Stock (140,000 units at $13.82) and acquired 668,326 shares, increasing direct ownership by 141% to 995,908 units (SEC Form 4)

    4 - FORD MOTOR CO (0000037996) (Issuer)

    2/23/26 4:30:27 PM ET
    $F
    Auto Manufacturing
    Industrials

    Chief Executive Officer Risher John David bought $100,179 worth of shares (7,490 units at $13.38), increasing direct ownership by 0.07% to 11,481,792 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    2/18/26 4:10:21 PM ET
    $LYFT
    Real Estate

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ADXN
    $AKA
    $ARAV
    $BCAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Oxford Industries with a new price target

    Telsey Advisory Group reiterated coverage of Oxford Industries with a rating of Market Perform and set a new price target of $51.00 from $36.00 previously

    4/22/26 6:45:43 AM ET
    $OXM
    Garments and Clothing
    Industrials

    Innoviz Technologies downgraded by Goldman with a new price target

    Goldman downgraded Innoviz Technologies from Buy to Neutral and set a new price target of $0.75

    4/14/26 8:15:50 AM ET
    $INVZ
    Auto Parts:O.E.M.
    Consumer Discretionary

    Ford Motor upgraded by UBS with a new price target

    UBS upgraded Ford Motor from Neutral to Buy and set a new price target of $15.00

    4/14/26 8:12:44 AM ET
    $F
    Auto Manufacturing
    Industrials

    $ADXN
    $AKA
    $ARAV
    $BCAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Whiteside Janey

    4 - Lyft, Inc. (0001759509) (Issuer)

    4/22/26 8:30:33 PM ET
    $LYFT
    Real Estate

    SEC Form 4 filed by Stephenson Dave

    4 - Lyft, Inc. (0001759509) (Issuer)

    4/22/26 8:28:45 PM ET
    $LYFT
    Real Estate

    SEC Form 4 filed by Ra Capital Management, L.P.

    4 - Vor Biopharma Inc. (0001817229) (Issuer)

    4/21/26 7:04:06 PM ET
    $VOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADXN
    $AKA
    $ARAV
    $BCAN
    SEC Filings

    View All

    SEC Form 6-K filed by Melco Resorts & Entertainment Limited

    6-K - Melco Resorts & Entertainment LTD (0001381640) (Filer)

    4/24/26 6:30:11 AM ET
    $MLCO
    Hotels/Resorts
    Consumer Discretionary

    SEC Form 6-K filed by Studio City International Holdings Limited

    6-K - STUDIO CITY INTERNATIONAL HOLDINGS Ltd (0001713334) (Filer)

    4/24/26 6:30:15 AM ET
    $MSC
    Hotels/Resorts
    Consumer Discretionary

    Mobile Global Esports Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Mobile Global Esports, Inc. (0001886362) (Filer)

    4/23/26 9:23:24 PM ET
    $MGAM
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ADXN
    $AKA
    $ARAV
    $BCAN
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

    Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability supported by gross margins of approximately 75%NOOR Collagen alone is projected to generate more than $12 million in annualized revenue Strong growth expected ahead, driven by organic progress and M&A pipeline including a recent LOI to acquire an $11.5 million pharmacy distribution network Holds valuable non-core strategic real estate and digital assets with an estimated fair market value exceeding $18 million, providing meaningful balance sheet flexibilityEvaluating potential monetization

    3/19/26 12:45:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ADXN
    $AKA
    $ARAV
    $BCAN
    Financials

    Live finance-specific insights

    View All

    Lyft Expands in London with Gett UK Acquisition

    Key takeaways: Lyft has agreed to acquire Gett's United Kingdom business with close expected in the coming weeks, subject to customary closing conditions. Gett is one of London's leading black cab apps with strong enterprise business-to-business (B2B) relationships, and brings together the majority of Greater London's registered black cab drivers and will nearly double the number of rides on the Lyft platform in London. With Gett, Lyft is expanding its coverage of London's full ground transport ecosystem. This advances Lyft's sustainable global growth strategy, while expanding "out" in more locations and "up" into more high-value segments. Lyft (NASDAQ:LYFT) has agreed to acq

    4/23/26 8:48:00 AM ET
    $LYFT
    Real Estate

    Innoviz Sets First Quarter 2026 Conference Call for Thursday, May 14 at 9:00 a.m. ET

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- Innoviz Technologies Ltd. (NASDAQ:INVZ), (the "Company" or "Innoviz"), a leading supplier of high performance, automotive-grade LiDAR sensor platforms, today announced that it will release its earnings results for the first quarter ended March 31, 2026 on Thursday, May 14, 2026 before the market opens. Innoviz will host a conference call and webinar on the same day at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time) to discuss its operational and financial results followed by a question-and-answer session for the investment community. Operational and financial results will be issued in a press release prior to the call.Investors are invited to

    4/23/26 8:00:00 AM ET
    $INVZ
    Auto Parts:O.E.M.
    Consumer Discretionary

    Sotera Health Announces First-Quarter 2026 Earnings Release Date

    CLEVELAND, April 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2026 before the market opens on Tuesday, May 5, 2026. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company's operating and financial results. A live webcast of the conference call and accompanying materials can be accessed via the Investor Relations section of the Company's website at Presentation & Event

    4/21/26 7:46:03 AM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    $ADXN
    $AKA
    $ARAV
    $BCAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Lyft Inc.

    SC 13G/A - Lyft, Inc. (0001759509) (Subject)

    12/4/24 2:38:58 PM ET
    $LYFT
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Innoviz Technologies Ltd.

    SC 13G/A - Innoviz Technologies Ltd. (0001835654) (Subject)

    11/14/24 8:27:58 PM ET
    $INVZ
    Auto Parts:O.E.M.
    Consumer Discretionary